"$d_webRawe"'Pandemics, health, and the Sun/corona virus/22011 xxyiorgos, Reddit, covax adverse effects paper list, Eh Myo-car-whut.txt'
www.BillHowell.ca 25Jan2022 

https://www.reddit.com/r/CoronavirusCirclejerk/comments/rzsbdj/eh_myocarwhut/


Press J to jump to the feed. Press question mark to learn the rest of the keyboard shortcuts
Search within r/CoronavirusCirclejerk
Subreddit Iconr/CoronavirusCirclejerk
Log In
Sign Up
Found the internet!
137
Eh? Myo-car-whut?
But wait, there’s more!!!
137
Posted byu/xxyiorgos
16 days ago
Silver
Eh? Myo-car-whut?
But wait, there’s more!!!

Cerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/

Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death after ChAdOx1 nCoV-19 vaccination:

https://www.sciencedirect.com/science/article/pii/S1052305721003414

Fatal cerebral hemorrhage after COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/33928772/

Myocarditis after mRNA vaccination against SARS-CoV-2, a case series:

https://www.sciencedirect.com/science/article/pii/S2666602221000409

Three cases of acute venous thromboembolism in women after vaccination against COVID-19:

https://www.sciencedirect.com/science/article/pii/S2213333X21003929

Acute thrombosis of the coronary tree after vaccination against COVID-19:

https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988

US case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S (against covid-19), March 2 to April 21, 2020:

https://pubmed.ncbi.nlm.nih.gov/33929487/

Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccine:

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/

Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET):

https://pubmed.ncbi.nlm.nih.gov/33871350/

Vaccine-induced immune immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review:

https://www.sciencedirect.com/science/article/pii/S0022510X21003014

Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines:

https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381

Covid-19 vaccine-induced thrombosis and thrombocytopenia: a commentary on an important and practical clinical dilemma:

https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505

Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines:

https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904

COVID-19 vaccine-induced immune-immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis:

https://www.sciencedirect.com/science/article/pii/S1665268121000557

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic immune thrombocytopenia (covid):

https://www.sciencedirect.com/science/article/pii/S1050173821000967

Roots of autoimmunity of thrombotic events after COVID-19 vaccination:

https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160

Cerebral venous sinus thrombosis after vaccination: the United Kingdom experience:

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext

Thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine:

https://www.nejm.org/doi/full/10.1056/nejme2106315

Myocarditis after immunization with COVID-19 mRNA vaccines in members of the US military. This article reports that in “23 male patients, including 22 previously healthy military members, myocarditis was identified within 4 days after receipt of the vaccine”:

https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601

Thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19:

https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article

Association of myocarditis with the BNT162b2 messenger RNA COVID-19 vaccine in a case series of children:

https://pubmed.ncbi.nlm.nih.gov/34374740/

Thrombotic thrombocytopenia after vaccination with ChAdOx1 nCov-19:

https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_article

Post-mortem findings in vaccine-induced thrombotic thrombocytopenia (covid-19):

https://haematologica.org/article/view/haematol.2021.279075
45 comments
98% Upvoted
Log in or sign up to leave a comment
Log In
Sign Up
level 1
randomaccnt231
·
16 days ago
I EAT HORSE FOOD! 🍎🍏🥕🌾

https://archive.is/u5M5u

Saved your impressive work for posterity.
28
level 2
Whole_Shape9055
·
16 days ago

The two of you are gems. Thank you!
6
level 1
xxyiorgos
Op ·
16 days ago

Thrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS):

https://www.sciencedirect.com/science/article/pii/S0264410X21005247

Acute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccination:

https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478

Aphasia seven days after the second dose of an mRNA-based SARS-CoV-2 vaccine. Brain MRI revealed an intracerebral hemorrhage (ICBH) in the left temporal lobe in a 52-year-old man.

https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005

Comparison of vaccine-induced thrombotic episodes between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines:

https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895

Hypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination:

https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315

Blood clots and bleeding episodes after BNT162b2 and ChAdOx1 nCoV-19 vaccination: analysis of European data:

https://www.sciencedirect.com/science/article/pii/S0896841121000937

Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine:

https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098

Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT):

https://www.sciencedirect.com/science/article/pii/S0953620521002363

Myocarditis and pericarditis after vaccination with COVID-19 mRNA: practical considerations for care providers:

https://www.sciencedirect.com/science/article/pii/S0828282X21006243

“Portal vein thrombosis occurring after the first dose of SARS-CoV-2 mRNA vaccine in a patient with antiphospholipid syndrome”:

https://www.sciencedirect.com/science/article/pii/S2666572721000389

Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S:

https://www.sciencedirect.com/science/article/pii/S0196064421003425

Myocarditis, pericarditis and cardiomyopathy after COVID-19 vaccination:

https://www.sciencedirect.com/science/article/pii/S1443950621011562

Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection:

https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706

Prothrombotic immune thrombocytopenia after COVID-19 vaccination:

https://www.sciencedirect.com/science/article/pii/S0006497121009411

Vaccine-induced thrombotic thrombocytopenia: the dark chapter of a success story:

https://www.sciencedirect.com/science/article/pii/S2589936821000256

Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin based anticoagulation:

https://www.sciencedirect.com/science/article/pii/S1871402121002046

Thrombosis after COVID-19 vaccination: possible link to ACE pathways:

https://www.sciencedirect.com/science/article/pii/S0049384821004369

Cerebral venous sinus thrombosis in the U.S. population after SARS-CoV-2 vaccination with adenovirus and after COVID-19:

https://www.sciencedirect.com/science/article/pii/S0735109721051949

A rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19 vaccination:

https://www.sciencedirect.com/science/article/pii/S0735675721005714

Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom:

https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19):

https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963.

Antiphospholipid antibodies and risk of thrombophilia after COVID-19 vaccination: the straw that breaks the camel’s back?:

https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ

Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against the COVID-19 pandemic: What pathogenesis?:

https://www.sciencedirect.com/science/article/pii/S0953620521002314

Diagnostic-therapeutic recommendations of the ad-hoc FACME expert working group on the management of cerebral venous thrombosis related to COVID-19 vaccination:

https://www.sciencedirect.com/science/article/pii/S0213485321000839

Thrombocytopenia and intracranial venous sinus thrombosis after exposure to the “AstraZeneca COVID-19 vaccine”:

https://pubmed.ncbi.nlm.nih.gov/33918932/

Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/33606296/

Severe and refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/33854395/

Purpuric rash and thrombocytopenia after mRNA-1273 (Modern) COVID-19 vaccine:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/

COVID-19 vaccination: information on the occurrence of arterial and venous thrombosis using data from VigiBase:

https://pubmed.ncbi.nlm.nih.gov/33863748/

Cerebral venous thrombosis associated with the covid-19 vaccine in Germany:

https://onlinelibrary.wiley.com/doi/10.1002/ana.26172

Cerebral venous thrombosis following BNT162b2 mRNA vaccination of BNT162b2 against SARS-CoV-2: a black swan event:

https://pubmed.ncbi.nlm.nih.gov/34133027/
12
level 2
xxyiorgos
Op ·
16 days ago

The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34001390/

Thrombosis with thrombocytopenia after messenger RNA vaccine -1273:

https://pubmed.ncbi.nlm.nih.gov/34181446/

Blood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data:

https://pubmed.ncbi.nlm.nih.gov/34174723/

First dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland:

https://www.nature.com/articles/s41591-021-01408-4

Exacerbation of immune thrombocytopenia after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34075578/

First report of a de novo iTTP episode associated with a COVID-19 mRNA-based anti-COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34105244/

PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia:

https://www.nejm.org/doi/full/10.1056/NEJMc2106383

Antibody epitopes in vaccine-induced immune immune thrombotic thrombocytopenia:

https://www.nature.com/articles/s41586-021-03744-4

Myocarditis with COVID-19 mRNA vaccines:

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135

Myocarditis and pericarditis after COVID-19 vaccination:

https://jamanetwork.com/journals/jama/fullarticle/2782900

Myocarditis temporally associated with COVID-19 vaccination:

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891

COVID-19 Vaccination Associated with Myocarditis in Adolescents:

https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf

Acute myocarditis after administration of BNT162b2 vaccine against COVID-19:

https://pubmed.ncbi.nlm.nih.gov/33994339/

Temporal association between COVID-19 vaccine Ad26.COV2.S and acute myocarditis: case report and review of the literature:

https://www.sciencedirect.com/science/article/pii/S1553838921005789

COVID-19 vaccine-induced myocarditis: a case report with review of the literature:

https://www.sciencedirect.com/science/article/pii/S1871402121002253

Potential association between COVID-19 vaccine and myocarditis: clinical and CMR findings:

https://www.sciencedirect.com/science/article/pii/S1936878X2100485X

Recurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent:

https://www.sciencedirect.com/science/article/pii/S002234762100617X

Fulminant myocarditis and systemic hyper inflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients:

https://www.sciencedirect.com/science/article/pii/S0167527321012286.

Acute myocarditis after administration of BNT162b2 vaccine:

https://www.sciencedirect.com/science/article/pii/S2214250921001530

Lymphohistocytic myocarditis after vaccination with COVID-19 Ad26.COV2.S viral vector:

https://www.sciencedirect.com/science/article/pii/S2352906721001573

Myocarditis following vaccination with BNT162b2 in a healthy male:

https://www.sciencedirect.com/science/article/pii/S0735675721005362

Acute myocarditis after Comirnaty (Pfizer) vaccination in a healthy male with previous SARS-CoV-2 infection:

https://www.sciencedirect.com/science/article/pii/S1930043321005549

Myopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents:

https://www.sciencedirect.com/science/article/pii/S002234762100665X

Pericarditis after administration of BNT162b2 mRNA COVID-19 mRNA vaccine:

https://www.sciencedirect.com/science/article/pii/S1885585721002218

Acute myocarditis after vaccination with SARS-CoV-2 mRNA-1273 mRNA:

https://www.sciencedirect.com/science/article/pii/S2589790X21001931

Temporal relationship between the second dose of BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection:

https://www.sciencedirect.com/science/article/pii/S2352906721000622

Myopericarditis after vaccination with COVID-19 mRNA in adolescents 12 to 18 years of age:

https://www.sciencedirect.com/science/article/pii/S0022347621007368

Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man:

https://www.sciencedirect.com/science/article/pii/S0870255121003243

Important information on myopericarditis after vaccination with Pfizer COVID-19 mRNA in adolescents:

https://www.sciencedirect.com/science/article/pii/S0022347621007496

A series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2:

https://www.sciencedirect.com/science/article/pii/S1936878X21004861

Takotsubo cardiomyopathy after vaccination with mRNA COVID-19:

https://www.sciencedirect.com/science/article/pii/S1443950621011331

COVID-19 mRNA vaccination and myocarditis:

https://pubmed.ncbi.nlm.nih.gov/34268277/

COVID-19 vaccine and myocarditis:

https://pubmed.ncbi.nlm.nih.gov/34399967/
8
Continue this thread 
level 1
lunchbasket69
·
16 days ago

Holy shit. Thanks OP!
11
level 1
SecureDeparture7420
·
16 days ago

Safe and effective
9
level 1
mushroomsarefriends
·
16 days ago

Um no sweety a fact-checker who studied journalism already debunked this, safe and effective.
8
level 1
Milkpowder44
·
16 days ago

God damn
6
level 1
Packbear
·
16 days ago

Saving all of these
7
level 1
mmd5y7
·
16 days ago

HERO 👏
7
level 1
notarobat
·
16 days ago

Source?
19
level 1
xxyiorgos
Op ·
16 days ago

Allergic reactions after COVID-19 vaccination: putting the risk in perspective:

https://pubmed.ncbi.nlm.nih.gov/34463751/

Anaphylactic reactions to COVID-19 mRNA vaccines: a call for further studies:

https://pubmed.ncbi.nlm.nih.gov/33846043/

Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin disease: practical recommendations. An ETFAD position statement with external experts:

https://pubmed.ncbi.nlm.nih.gov/33752263/

COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis:

https://pubmed.ncbi.nlm.nih.gov/34073536/

Fatal brain hemorrhage after COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/33928772/

A case series of skin reactions to COVID-19 vaccine in the Department of Dermatology at Loma Linda University:

https://pubmed.ncbi.nlm.nih.gov/34423106/

Skin reactions reported after Moderna and Pfizer’s COVID-19 vaccination: a study based on a registry of 414 cases:

https://pubmed.ncbi.nlm.nih.gov/33838206/

Clinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V-REPP: a registry-based study:

https://pubmed.ncbi.nlm.nih.gov/34517079/

Skin reactions after vaccination against SARS-COV-2: a nationwide Spanish cross-sectional study of 405 cases:

https://pubmed.ncbi.nlm.nih.gov/34254291/

Varicella zoster virus and herpes simplex virus reactivation after vaccination with COVID-19: review of 40 cases in an international dermatologic registry:

https://pubmed.ncbi.nlm.nih.gov/34487581/

Immune thrombosis and thrombocytopenia (VITT) associated with the COVID-19 vaccine: diagnostic and therapeutic recommendations for a new syndrome:

https://pubmed.ncbi.nlm.nih.gov/33987882/

Laboratory testing for suspicion of COVID-19 vaccine-induced thrombotic (immune) thrombocytopenia:

https://pubmed.ncbi.nlm.nih.gov/34138513/

Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: the first fatal case in Korea:

https://pubmed.ncbi.nlm.nih.gov/34402235/

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-2 tests: self-controlled case series study:

https://pubmed.ncbi.nlm.nih.gov/34446426/

Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after covid-19 vaccination; a systematic review:

https://pubmed.ncbi.nlm.nih.gov/34365148/

Nerve and muscle adverse events after vaccination with COVID-19: a systematic review and meta-analysis of clinical trials:

https://pubmed.ncbi.nlm.nih.gov/34452064/

A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated with administration of COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/33917902/

Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT):

https://pubmed.ncbi.nlm.nih.gov/34256983/

Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34247246/

Thromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of AstraZeneca COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34132839/

59-year-old woman with extensive deep venous thrombosis and pulmonary thromboembolism 7 days after a first dose of Pfizer-BioNTech BNT162b2 mRNA vaccine COVID-19:

https://pubmed.ncbi.nlm.nih.gov/34117206/

Cerebral venous thrombosis and vaccine-induced thrombocytopenia.a. Oxford-AstraZeneca COVID-19: a missed opportunity for a rapid return on experience:

https://pubmed.ncbi.nlm.nih.gov/34033927/

Myocarditis and other cardiovascular complications of mRNA-based COVID-19 vaccines:

https://pubmed.ncbi.nlm.nih.gov/34277198/

Pericarditis after administration of COVID-19 mRNA BNT162b2 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34364831/

Unusual presentation of acute pericarditis after vaccination against SARS-COV-2 mRNA-1237 Moderna:

https://pubmed.ncbi.nlm.nih.gov/34447639/

Case report: acute myocarditis after second dose of SARS-CoV-2 mRNA-1273 vaccine mRNA-1273:

https://pubmed.ncbi.nlm.nih.gov/34514306/

Immune-mediated disease outbreaks or recent-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2:

https://pubmed.ncbi.nlm.nih.gov/33946748/

Insights from a murine model of myopericarditis induced by COVID-19 mRNA vaccine: could accidental intravenous injection of a vaccine induce myopericarditis:

https://pubmed.ncbi.nlm.nih.gov/34453510/

Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/33476455/

propylthiouracil-induced neutrophil anti-cytoplasmic antibody-associated vasculitis after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34451967/

Secondary immune thrombocytopenia (ITP) associated with ChAdOx1 Covid-19 vaccine: case report:

https://pubmed.ncbi.nlm.nih.gov/34377889/

Thrombosis with thrombocytopenia syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination: risk-benefit analysis for persons <60 years in Australia:

https://pubmed.ncbi.nlm.nih.gov/34272095/

COVID-19 vaccination association and facial nerve palsy: A case-control study:

https://pubmed.ncbi.nlm.nih.gov/34165512/
4
level 2
xxyiorgos
Op ·
16 days ago

The association between COVID-19 vaccination and Bell’s palsy:

https://pubmed.ncbi.nlm.nih.gov/34411533/

Bell’s palsy after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/33611630/

Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 vaccine (AZD1222):

https://pubmed.ncbi.nlm.nih.gov/33981305/

Bell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 mRNA-1273 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34336436/

Sequential contralateral facial nerve palsy after first and second doses of COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34281950/.

Transverse myelitis induced by SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34458035/

Peripheral facial nerve palsy after vaccination with BNT162b2 (COVID-19):

https://pubmed.ncbi.nlm.nih.gov/33734623/

Acute abducens nerve palsy after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34044114/

Facial nerve palsy after administration of COVID-19 mRNA vaccines: analysis of self-report database:

https://pubmed.ncbi.nlm.nih.gov/34492394/

Transient oculomotor paralysis after administration of RNA-1273 messenger vaccine for SARS-CoV-2 diplopia after COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34369471/

Bell’s palsy after Ad26.COV2.S COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34014316/

Bell’s palsy after COVID-19 vaccination: case report:

https://pubmed.ncbi.nlm.nih.gov/34330676/

A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy following ChAdOx1 nCoV-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34272622/

Guillian Barré syndrome after vaccination with mRNA-1273 against COVID-19:

https://pubmed.ncbi.nlm.nih.gov/34477091/

Acute facial paralysis as a possible complication of SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/33975372/

Bell’s palsy after COVID-19 vaccination with high antibody response in CSF:

https://pubmed.ncbi.nlm.nih.gov/34322761/

Parsonage-Turner syndrome associated with SARS-CoV-2 or SARS-CoV-2 vaccination. Comment on: “Neuralgic amyotrophy and COVID-19 infection: 2 cases of accessory spinal nerve palsy”

https://pubmed.ncbi.nlm.nih.gov/34139321/

Bell’s palsy after a single dose of vaccine mRNA. SARS-CoV-2: case report:

https://pubmed.ncbi.nlm.nih.gov/34032902/

Autoimmune hepatitis developing after coronavirus disease vaccine 2019 (COVID-19): causality or victim?:

https://pubmed.ncbi.nlm.nih.gov/33862041/

Autoimmune hepatitis triggered by vaccination against SARS-CoV-2:

https://pubmed.ncbi.nlm.nih.gov/34332438/

Acute autoimmune-like hepatitis with atypical antimitochondrial antibody after vaccination with COVID-19 mRNA: a new clinical entity:

https://pubmed.ncbi.nlm.nih.gov/34293683/

Autoimmune hepatitis after COVID vaccine:

https://pubmed.ncbi.nlm.nih.gov/34225251/

A novel case of bifacial diplegia variant of Guillain-Barré syndrome after vaccination with Janssen COVID-19:

https://pubmed.ncbi.nlm.nih.gov/34449715/

Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines:

https://pubmed.ncbi.nlm.nih.gov/34139631/

Bilateral superior ophthalmic vein thrombosis, ischemic stroke and immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19:

https://pubmed.ncbi.nlm.nih.gov/33864750/

Diagnosis and treatment of cerebral venous sinus thrombosis with vaccine-induced immune-immune thrombotic thrombocytopenia:

https://pubmed.ncbi.nlm.nih.gov/33914590/

Venous sinus thrombosis after vaccination with ChAdOx1 nCov-19:

https://pubmed.ncbi.nlm.nih.gov/34420802/

Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency:

https://pubmed.ncbi.nlm.nih.gov/34293217/
4
Continue this thread 
level 1
xxyiorgos
Op ·
16 days ago

COVID-19 mRNA vaccine causing CNS inflammation: a case series:

https://pubmed.ncbi.nlm.nih.gov/34480607/

Thymic hyperplasia after Covid-19 mRNA-based vaccination with Covid-19:

https://pubmed.ncbi.nlm.nih.gov/34462647/

Acute disseminated encephalomyelitis following vaccination against SARS-CoV-2:

https://pubmed.ncbi.nlm.nih.gov/34325334/

Tolosa-Hunt syndrome occurring after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34513398/

Systemic capillary extravasation syndrome following vaccination with ChAdOx1 nCOV-19 (Oxford-AstraZeneca):

https://pubmed.ncbi.nlm.nih.gov/34362727/

Immune-mediated thrombocytopenia associated with Ad26.COV2.S vaccine (Janssen; Johnson & Johnson):

https://pubmed.ncbi.nlm.nih.gov/34469919/

Transient thrombocytopenia with glycoprotein-specific platelet autoantibodies after vaccination with Ad26.COV2.S: case report:

https://pubmed.ncbi.nlm.nih.gov/34516272/

Acute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: case report:

https://pubmed.ncbi.nlm.nih.gov/34512961/

Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34077949/

Autoimmune hepatitis developing after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca):

https://pubmed.ncbi.nlm.nih.gov/34171435/

Severe relapse of multiple sclerosis after COVID-19 vaccination: a case report:

https://pubmed.ncbi.nlm.nih.gov/34447349/

Lymphohistocytic myocarditis after vaccination with the COVID-19 viral vector Ad26.COV2.S:

https://pubmed.ncbi.nlm.nih.gov/34514078/

Hemophagocytic lymphohistiocytosis after vaccination with ChAdOx1 nCov-19:

https://pubmed.ncbi.nlm.nih.gov/34406660/

IgA vasculitis in adult patient after vaccination with ChadOx1 nCoV-19:

https://pubmed.ncbi.nlm.nih.gov/34509658/

A case of leukocytoclastic vasculitis after vaccination with a SARS-CoV2 vaccine: case report:

https://pubmed.ncbi.nlm.nih.gov/34196469/

Onset / outbreak of psoriasis after Corona virus ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca / Covishield): report of two cases:

https://pubmed.ncbi.nlm.nih.gov/34350668/

Hailey-Hailey disease exacerbation after SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34436620/

Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography:

https://pubmed.ncbi.nlm.nih.gov/34116295/

COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern in cases with underlying hepatic problems:

https://pubmed.ncbi.nlm.nih.gov/34509271/

Report of the International Cerebral Venous Thrombosis Consortium on cerebral venous thrombosis after SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34462996/

Immune thrombocytopenia after vaccination during the COVID-19 pandemic:

https://pubmed.ncbi.nlm.nih.gov/34435486/

COVID-19: lessons from the Norwegian tragedy should be taken into account in planning for vaccine launch in less developed/developing countries:

https://pubmed.ncbi.nlm.nih.gov/34435142/

Rituximab-induced acute lympholysis and pancytopenia following vaccination with COVID-19:

https://pubmed.ncbi.nlm.nih.gov/34429981/

Exacerbation of plaque psoriasis after COVID-19 inactivated mRNA and BNT162b2 vaccines: report of two cases:

https://pubmed.ncbi.nlm.nih.gov/34427024/

Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34510014/

Vesiculobullous cutaneous reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature:

https://pubmed.ncbi.nlm.nih.gov/34236711/

Vaccine-induced thrombocytopenia with severe headache:

https://pubmed.ncbi.nlm.nih.gov/34525282/

Acute perimyocarditis after the first dose of COVID-19 mRNA vaccine:

https://pubmed.ncbi.nlm.nih.gov/34515024/

Rhabdomyolysis and fasciitis induced by COVID-19 mRNA vaccine:

https://pubmed.ncbi.nlm.nih.gov/34435250/

Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature:

https://pubmed.ncbi.nlm.nih.gov/34363637/

Immune thrombocytopenia associated with the Pfizer-BioNTech COVID-19 mRNA vaccine BNT162b2:

https://www.sciencedirect.com/science/article/pii/S2214250921002018

Secondary immune thrombocytopenia putatively attributable to COVID-19 vaccination:

https://casereports.bmj.com/content/14/5/e242220.abstract.

Immune thrombocytopenia following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34155844/

Newly diagnosed idiopathic thrombocytopenia after COVID-19 vaccine administration:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/

Idiopathic thrombocytopenic purpura and the Modern Covid-19 vaccine:

https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext.

Thrombocytopenia after Pfizer and Moderna SARS vaccination – CoV -2:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/

Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccination:

https://casereports.bmj.com/content/14/7/e242678
5
level 2
xxyiorgos
Op ·
16 days ago

Collection of complement-mediated and autoimmune-mediated hematologic conditions after SARS-CoV-2 vaccination:

https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic

Petechial rash associated with CoronaVac vaccination: first report of cutaneous side effects before phase 3 results:

https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794

COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria:

https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in

Cerebral venous thrombosis associated with COVID-19 vaccine in Germany:

https://pubmed.ncbi.nlm.nih.gov/34288044/

Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management:

https://pubmed.ncbi.nlm.nih.gov/34327553/

Cerebral venous thrombosis and thrombocytopenia after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/33878469/

Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom:

https://pubmed.ncbi.nlm.nih.gov/33857630/

Cerebral venous thrombosis induced by SARS-CoV-2 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34090750/

Carotid artery immune thrombosis induced by adenovirus-vectored COVID-19 vaccine: case report:

https://pubmed.ncbi.nlm.nih.gov/34312301/

Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia:

https://pubmed.ncbi.nlm.nih.gov/34333995/

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune-immune thrombotic thrombocytopenia:

https://pubmed.ncbi.nlm.nih.gov/34455073/

Cerebral venous thrombosis after the BNT162b2 mRNA SARS-CoV-2 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34111775/

Cerebral venous thrombosis after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34045111/

Lethal cerebral venous sinus thrombosis after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/33983464/

Cerebral venous sinus thrombosis in the U.S. population, After SARS-CoV-2 vaccination with adenovirus and after COVID-19:

https://pubmed.ncbi.nlm.nih.gov/34116145/

Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular administration of the vaccine:

https://pubmed.ncbi.nlm.nih.gov/34286453/

Central venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental:

https://pubmed.ncbi.nlm.nih.gov/34478433/

Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first brain MRI:

https://pubmed.ncbi.nlm.nih.gov/34244448/

Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S:

https://pubmed.ncbi.nlm.nih.gov/34226070/

Cerebral venous sinus thrombosis associated with post-vaccination thrombocytopenia by COVID-19:

https://pubmed.ncbi.nlm.nih.gov/33845870/

Cerebral venous sinus thrombosis 2 weeks after the first dose of SARS-CoV-2 mRNA vaccine:

https://pubmed.ncbi.nlm.nih.gov/34101024/

Vaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with a high mortality rate: a case series:

https://pubmed.ncbi.nlm.nih.gov/34393988/

Adenovirus interactions with platelets and coagulation and vaccine-associated autoimmune thrombocytopenia thrombosis syndrome:

https://pubmed.ncbi.nlm.nih.gov/34407607/

Headache attributed to COVID-19 (SARS-CoV-2 coronavirus) vaccination with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study:

https://pubmed.ncbi.nlm.nih.gov/34313952/

Adverse effects reported after COVID-19 vaccination in a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST):

https://pubmed.ncbi.nlm.nih.gov/34092166/

Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency:

https://pubmed.ncbi.nlm.nih.gov/34293217/

A rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination:

https://pubmed.ncbi.nlm.nih.gov/34274191/

Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study:

https://pubmed.ncbi.nlm.nih.gov/33952445/

Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis:

https://pubmed.ncbi.nlm.nih.gov/34129181/

U.S. case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S, March 2-April 21, 2021:

https://pubmed.ncbi.nlm.nih.gov/33929487/

Malignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia:

https://pubmed.ncbi.nlm.nih.gov/34341358/
5
Continue this thread 
level 1
xxyiorgos
Op ·
16 days ago

Neurological side effects of SARS-CoV-2 vaccines:

https://pubmed.ncbi.nlm.nih.gov/34750810/

Coagulopathies after SARS-CoV-2 vaccination may derive from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-activated signaling pathways:

https://pubmed.ncbi.nlm.nih.gov/34639132/

Isolated pulmonary embolism after COVID vaccination: 2 case reports and a review of acute pulmonary embolism complications and follow-up:

https://pubmed.ncbi.nlm.nih.gov/34804412/

Central retinal vein occlusion after vaccination with SARS-CoV-2 mRNA: case report:

https://pubmed.ncbi.nlm.nih.gov/34571653/

Complicated case report of long-term vaccine-induced thrombotic immune thrombocytopenia A:

https://pubmed.ncbi.nlm.nih.gov/34835275/

Deep venous thrombosis after vaccination with Ad26.COV2.S in adult males:

https://pubmed.ncbi.nlm.nih.gov/34659839/

Neurological autoimmune diseases after SARS-CoV-2 vaccination: a case series:

https://pubmed.ncbi.nlm.nih.gov/34668274/

Severe autoimmune hemolytic autoimmune anemia after receiving SARS-CoV-2 mRNA vaccine:

https://pubmed.ncbi.nlm.nih.gov/34549821/

Occurrence of COVID-19 variants among recipients of ChAdOx1 nCoV-19 vaccine (recombinant):

https://pubmed.ncbi.nlm.nih.gov/34528522/

Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies, and elevated D-dimer in Thais after vaccination with ChAdOx1 nCoV-19:

https://pubmed.ncbi.nlm.nih.gov/34568726/

Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination:

https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/644 5179

Myocarditis after 2019 coronavirus disease mRNA vaccine: a case series and determination of incidence rate:

https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408

Myocarditis and pericarditis after COVID-19 vaccination: inequalities in age and vaccine types:

https://www.mdpi.com/2075-4426/11/11/1106

Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study:

https://pubmed.ncbi.nlm.nih.gov/34402230/

Shedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients:

https://pubmed.ncbi.nlm.nih.gov/34696294/

Myocarditis Following mRNA COVID-19 Vaccine:

https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_ mRNA_COVID_19_Vaccine.9.aspx.

Myocarditis following BNT162b2 mRNA Covid-19 mRNA vaccine in Israel:

https://pubmed.ncbi.nlm.nih.gov/34614328/

Myocarditis, pericarditis, and cardiomyopathy following COVID-19 vaccination:

https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext

Myocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines:

https://pubmed.ncbi.nlm.nih.gov/34277198/

Possible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings:

https://pubmed.ncbi.nlm.nih.gov/34246586/

Hypersensitivity Myocarditis and COVID-19 Vaccines:

https://pubmed.ncbi.nlm.nih.gov/34856634/

Severe myocarditis associated with COVID-19 vaccine: zebra or unicorn?:

https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext

Acute myocardial infarction and myocarditis after COVID-19 vaccination:

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/

Myocarditis after Covid-19 vaccination in a large healthcare organization:

https://www.nejm.org/doi/10.1056/NEJMoa2110737

Association of myocarditis with COVID-19 messenger RNA BNT162b2 vaccine in a case series of children:

https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052

Clinical suspicion of myocarditis temporally related to COVID-19 vaccination in adolescents and young adults:

https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

STEMI mimicry: focal myocarditis in an adolescent patient after COVID-19 mRNA vaccination:

https://pubmed.ncbi.nlm.nih.gov/34756746/

Myocarditis and pericarditis in association with COVID-19 mRNA vaccination: cases from a regional pharmacovigilance center:

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/

Myocarditis after COVID-19 mRNA vaccines:

https://pubmed.ncbi.nlm.nih.gov/34546329/

Patients with acute myocarditis after COVID-19 mRNA vaccination:

https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602

Myocarditis after COVID-19 vaccination: a case series:

https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub.

Myocarditis associated with COVID-19 vaccination in adolescents:

https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357

Myocarditis findings on cardiac magnetic resonance imaging after vaccination with COVID-19 mRNA in adolescents:

https://pubmed.ncbi.nlm.nih.gov/34704459/
4
level 2
xxyiorgos
Op ·
16 days ago

Myocarditis after COVID-19 vaccination: magnetic resonance imaging study:

https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640

Acute myocarditis after administration of the second dose of BNT162b2 COVID-19 vaccine:

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/

Myocarditis after COVID-19 vaccination:

https://www.sciencedirect.com/science/article/pii/S2352906721001603

Case report: probable myocarditis after Covid-19 mRNA vaccine in a patient with arrhythmogenic left ventricular cardiomyopathy:

https://pubmed.ncbi.nlm.nih.gov/34712717/

Acute myocarditis after administration of BNT162b2 vaccine against COVID-19:

https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X

Myocarditis associated with COVID-19 mRNA vaccination:

https://pubs.rsna.org/doi/10.1148/radiol.2021211430

Acute myocarditis after COVID-19 vaccination: a case report:

https://www.sciencedirect.com/science/article/pii/S0248866321007098

Acute myopericarditis after COVID-19 vaccination in adolescents:

https://pubmed.ncbi.nlm.nih.gov/34589238/

Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccination:

https://academic.oup.com/jpids/article/10/10/962/6329543

Acute myocarditis associated with anti-COVID-19 vaccination:

https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196

Myocarditis associated with COVID-19 vaccination: echocardiographic, cardiac CT, and MRI findings:

https://pubmed.ncbi.nlm.nih.gov/34428917/

Acute symptomatic myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34088762/

Myocarditis and pericarditis in adolescents after first and second doses of COVID-19 mRNA vaccines:

https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104

COVID 19 vaccine for adolescents. Concern for myocarditis and pericarditis:

https://www.mdpi.com/2036-7503/13/3/61

Cardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA:

https://pubmed.ncbi.nlm.nih.gov/34402228/

Myocarditis temporally associated with COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34133885/

Acute myocardial injury after COVID-19 vaccination: a case report and review of current evidence from the vaccine adverse event reporting system database:

https://pubmed.ncbi.nlm.nih.gov/34219532/

Acute myocarditis associated with COVID-19 vaccination: report of a case:

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/

Myocarditis following vaccination with COVID-19 messenger RNA: a Japanese case series:

https://pubmed.ncbi.nlm.nih.gov/34840235/

Myocarditis in the setting of a recent COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34712497/.

Acute myocarditis after a second dose of COVID-19 mRNA vaccine: report of two cases:

https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext.

Prevalence of thrombocytopenia, antiplatelet factor 4 antibodies, and elevated D-dimer in Thais after vaccination with ChAdOx1 nCoV-19:

https://pubmed.ncbi.nlm.nih.gov/34568726/

Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination:

https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179

Myocarditis after 2019 coronavirus disease mRNA vaccine: a case series and incidence rate determination:

https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408.

Myocarditis and pericarditis after COVID-19 vaccination: inequalities in age and vaccine types:

https://www.mdpi.com/2075-4426/11/11/1106

Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study:

https://pubmed.ncbi.nlm.nih.gov/34402230/

Shedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients:

https://pubmed.ncbi.nlm.nih.gov/34696294/

Diffuse prothrombotic syndrome after administration of ChAdOx1 nCoV-19 vaccine: case report:

https://pubmed.ncbi.nlm.nih.gov/34615534/

Three cases of acute venous thromboembolism in women after coronavirus 2019 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34352418/

Clinical and biological features of cerebral venous sinus thrombosis after vaccination with ChAdOx1 nCov-19;

https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340.

CAd26.COV2-S vaccination may reveal hereditary thrombophilia: massive cerebral venous sinus thrombosis in a young man with normal platelet count:

https://pubmed.ncbi.nlm.nih.gov/34632750/

Post-mortem findings in vaccine-induced thrombotic thrombocytopenia:

https://haematologica.org/article/view/haematol.2021.279075

**COVID-19 vaccine-induced thrombosis:

https://pubmed.ncbi.nlm.nih.gov/34802488/

Inflammation and platelet activation after COVID-19 vaccines: possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis:

https://pubmed.ncbi.nlm.nih.gov/34887867/

**Anaphylactoid reaction and coronary thrombosis related to COVID-19 mRNA vaccine:

https://pubmed.ncbi.nlm.nih.gov/34863404/

Vaccine-induced cerebral venous thrombosis and thrombocytopenia. Oxford-AstraZeneca COVID-19: a missed opportunity for rapid return on experience:

https://www.sciencedirect.com/science/article/pii/S235255682100093X

Occurrence of splenic infarction due to arterial thrombosis after vaccination with COVID-19:

https://pubmed.ncbi.nlm.nih.gov/34876440/

Deep venous thrombosis more than two weeks after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/33928773/
5
Continue this thread 
level 1
xxyiorgos
Op ·
16 days ago

Guillain-Barre syndrome after COVID-19 vaccination in an adolescent:

https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext

Guillain-Barre syndrome after ChAdOx1-S / nCoV-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34114256/

Guillain-Barre syndrome after COVID-19 mRNA-1273 vaccine: case report:

https://pubmed.ncbi.nlm.nih.gov/34767184/

Guillain-Barre syndrome following SARS-CoV-2 vaccination in 19 patients:

https://pubmed.ncbi.nlm.nih.gov/34644738/

Guillain-Barre syndrome presenting with facial diplegia following vaccination with COVID-19 in two patients:

https://pubmed.ncbi.nlm.nih.gov/34649856/

A rare case of Guillain-Barré syndrome after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34671572/

Neurological complications of COVID-19: Guillain-Barre syndrome after Pfizer COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/33758714/

COVID-19 vaccine causing Guillain-Barre syndrome, an uncommon potential side effect:

https://pubmed.ncbi.nlm.nih.gov/34484780/

Guillain-Barre syndrome after the first dose of COVID-19 vaccination: case report;

https://pubmed.ncbi.nlm.nih.gov/34779385/

Miller Fisher syndrome after Pfizer COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34817727/

Miller Fisher syndrome after 2019 BNT162b2 mRNA coronavirus vaccination:

https://pubmed.ncbi.nlm.nih.gov/34789193/

Bilateral facial weakness with a variant of paresthesia of Guillain-Barre syndrome after Vaxzevria COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34261746/

Guillain-Barre syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report:

https://pubmed.ncbi.nlm.nih.gov/34217513/

A case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM1 antibodies after first dose of COVID-19 BNT162b2 mRNA vaccine (Pfizer):

https://pubmed.ncbi.nlm.nih.gov/34871447/

Reporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analysis in VigiBase:

https://pubmed.ncbi.nlm.nih.gov/34579259/

A variant of Guillain-Barré syndrome after SARS-CoV-2 vaccination: AMSAN:

https://pubmed.ncbi.nlm.nih.gov/34370408/

A rare variant of Guillain-Barré syndrome after vaccination with Ad26.COV2.S:

https://pubmed.ncbi.nlm.nih.gov/34703690/

Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome:

https://pubmed.ncbi.nlm.nih.gov/34810163/

Guillain-Barré syndrome in an Australian state using mRNA and adenovirus-vector SARS-CoV-2 vaccines:

https://onlinelibrary.wiley.com/doi/10.1002/ana.26218.

Acute transverse myelitis after SARS-CoV-2 vaccination: case report and review of the literature:

https://pubmed.ncbi.nlm.nih.gov/34482455/

Variant Guillain-Barré syndrome occurring after SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34114269/

Guillian-Barre syndrome with axonal variant temporally associated with Modern SARS-CoV-2 mRNA-based vaccine:

https://pubmed.ncbi.nlm.nih.gov/34722067/

Guillain-Barre syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association:

https://pubmed.ncbi.nlm.nih.gov/33968610/

SARS-CoV-2 vaccines can be complicated not only by Guillain-Barré syndrome but also by distal small fiber neuropathy:

https://pubmed.ncbi.nlm.nih.gov/34525410/

Clinical variant of Guillain-Barré syndrome with prominent facial diplegia after AstraZeneca 2019 coronavirus disease vaccine:

https://pubmed.ncbi.nlm.nih.gov/34808658/

Adverse event reporting and risk of Bell’s palsy after COVID-19 vaccination:

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext.

Bilateral facial nerve palsy and COVID-19 vaccination: causality or coincidence:

https://pubmed.ncbi.nlm.nih.gov/34522557/
6
level 2
xxyiorgos
Op ·
16 days ago

Left Bell’s palsy after the first dose of mRNA-1273 SARS-CoV-2 vaccine: case report:

https://pubmed.ncbi.nlm.nih.gov/34763263/

Bell’s palsy after inactivated vaccination with COVID-19 in a patient with a history of recurrent Bell’s palsy: case report:

https://pubmed.ncbi.nlm.nih.gov/34621891/

Neurological complications after the first dose of COVID-19 vaccines and SARS-CoV-2 infection:

https://pubmed.ncbi.nlm.nih.gov/34697502/

Type I interferons as a potential mechanism linking COVID-19 mRNA vaccines with Bell’s palsy:**

https://pubmed.ncbi.nlm.nih.gov/33858693/

Acute transverse myelitis following inactivated COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34370410/

Acute transverse myelitis after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34579245/.

A case of longitudinally extensive transverse myelitis following Covid-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34182207/

Post COVID-19 transverse myelitis; a case report with review of the literature:

https://pubmed.ncbi.nlm.nih.gov/34457267/

Beware of neuromyelitis optica spectrum disorder after vaccination with inactivated virus for COVID-19:

https://pubmed.ncbi.nlm.nih.gov/34189662/

Neuromyelitis optica in a healthy woman after vaccination against severe acute respiratory syndrome coronavirus 2 mRNA-1273:

https://pubmed.ncbi.nlm.nih.gov/34660149/

Acute bilateral bilateral optic neuritis/chiasm with longitudinal extensive transverse myelitis in long-standing stable multiple sclerosis after vector-based vaccination against SARS-CoV-2:

https://pubmed.ncbi.nlm.nih.gov/34131771/

A case series of acute pericarditis after vaccination with COVID-19 in the context of recent reports from Europe and the United States:

https://pubmed.ncbi.nlm.nih.gov/34635376/

Acute pericarditis and cardiac tamponade after vaccination with Covid-19:

https://pubmed.ncbi.nlm.nih.gov/34749492/

**Myocarditis and pericarditis in adolescents after the first and second doses of COVID-19 mRNA vaccines:

https://pubmed.ncbi.nlm.nih.gov/34849667/

Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34319393/

Acute myopericarditis after COVID-19 vaccine in adolescents:

https://pubmed.ncbi.nlm.nih.gov/34589238/

Pericarditis after administration of the BNT162b2 mRNA vaccine COVID-19:

https://pubmed.ncbi.nlm.nih.gov/34149145/

Case report: symptomatic pericarditis post COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34693198/

An outbreak of Still’s disease after COVID-19 vaccination in a 34-year-old patient:

https://pubmed.ncbi.nlm.nih.gov/34797392/

Hemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19):

https://pubmed.ncbi.nlm.nih.gov/34862234/

Myocarditis after SARS-CoV-2 mRNA vaccination, a case series:

https://pubmed.ncbi.nlm.nih.gov/34396358/

Miller-Fisher syndrome and Guillain-Barré syndrome overlap syndrome in a patient after Oxford-AstraZeneca SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34848426/

Immune-mediated disease outbreaks or new-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2:

https://pubmed.ncbi.nlm.nih.gov/33946748/

Post-mortem investigation of deaths after vaccination with COVID-19 vaccines:

https://pubmed.ncbi.nlm.nih.gov/34591186/

Acute kidney injury with macroscopic hematuria and IgA nephropathy after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34352309/

Relapse of immune thrombocytopenia after covid-19 vaccination in young male patient:

https://pubmed.ncbi.nlm.nih.gov/34804803/

Immune thrombocytopenic purpura associated with COVID-19 mRNA vaccine Pfizer-BioNTech BNT16B2b2:

https://pubmed.ncbi.nlm.nih.gov/34077572/

Retinal hemorrhage after SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34884407/

Case report: anti-neutrophil cytoplasmic antibody-associated vasculitis with acute renal failure and pulmonary hemorrhage can occur after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34859017/

Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: case report:

https://pubmed.ncbi.nlm.nih.gov/34783899/

Peduncular, symptomatic cavernous bleeding after immune thrombocytopenia-induced SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34549178/

Brain death in a vaccinated patient with COVID-19 infection:

https://pubmed.ncbi.nlm.nih.gov/34656887/

Generalized purpura annularis telangiectodes after SARS-CoV-2 mRNA vaccination:

https://pubmed.ncbi.nlm.nih.gov/34236717/

Lobar hemorrhage with ventricular rupture shortly after the first dose of a SARS-CoV-2 mRNA-based SARS-CoV-2 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34729467/

A case of outbreak of macroscopic hematuria and IgA nephropathy after SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/33932458/
4
Continue this thread 
level 1
xxyiorgos
Op ·
16 days ago

Lymphadenopathy associated with the COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/33786231/

Evolution of lymphadenopathy on PET/MRI after COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/33625301/

Autoimmune hepatitis triggered by SARS-CoV-2 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34332438/

New-onset nephrotic syndrome after Janssen COVID-19 vaccination: case report and literature review:

https://pubmed.ncbi.nlm.nih.gov/34342187/

Massive cervical lymphadenopathy following vaccination with COVID-19:

https://pubmed.ncbi.nlm.nih.gov/34601889/

ANCA glomerulonephritis following Modern COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34081948/

Extensive longitudinal transverse myelitis following AstraZeneca COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34507942/

Systemic capillary extravasation syndrome after vaccination with ChAdOx1 nCOV-19 (Oxford-AstraZeneca):

https://pubmed.ncbi.nlm.nih.gov/34362727/

Unilateral axillary lymphadenopathy related to COVID-19 vaccine: pattern on screening breast MRI allowing benign evaluation:

https://pubmed.ncbi.nlm.nih.gov/34325221/

Axillary lymphadenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma:

https://pubmed.ncbi.nlm.nih.gov/34825530/

Minimal change disease and acute kidney injury after Pfizer-BioNTech COVID-19 vaccine:

https://pubmed.ncbi.nlm.nih.gov/34000278/

COVID-19 vaccine-induced unilateral axillary adenopathy: follow-up evaluation in the USA:

https://pubmed.ncbi.nlm.nih.gov/34655312/

Gastroparesis after Pfizer-BioNTech COVID-19 vaccination:

https://pubmed.ncbi.nlm.nih.gov/34187985/

Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. Int J Cardiol, 340, 119-121. doi:10.1016/j.ijcard.2021.08.018.

https://www.ncbi.nlm.nih.gov/pubmed/34416319

Myocarditis following COVID-19 mRNA vaccination. Vaccine, 39(29), 3790-3793. doi:10.1016/j.vaccine.2021.05.087.

https://www.ncbi.nlm.nih.gov/pubmed/34092429

Myocarditis following COVID-19 vaccination. Radiol Case Rep, 16(8), 2142-2145. doi:10.1016/j.radcr.2021.05.033.

https://www.ncbi.nlm.nih.gov/pubmed/34025885

Acute Myocardial Infarction and Myocarditis following COVID-19 Vaccination. QJM. doi:10.1093/qjmed/hcab252.

https://www.ncbi.nlm.nih.gov/pubmed/34586408

STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. J Emerg Med, 61(6), e129-e132. doi:10.1016/j.jemermed.2021.09.017.

https://www.ncbi.nlm.nih.gov/pubmed/34756746

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med, 385(12), 1078-1090. doi:10.1056/NEJMoa2110475.

https://www.ncbi.nlm.nih.gov/pubmed/34432976

Coronavirus and cardiovascular manifestations- getting to the heart of the matter. World J Cardiol, 13(10), 556-565. doi:10.4330/wjc.v13.i10.556.

https://www.ncbi.nlm.nih.gov/pubmed/34754400

Myocarditis With COVID-19 mRNA Vaccines. Circulation, 144(6), 471-484. doi:10.1161/CIRCULATIONAHA.121.056135.

https://www.ncbi.nlm.nih.gov/pubmed/34281357

Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome? Vaccines (Basel), 9(11). doi:10.3390/vaccines9111353.

https://www.ncbi.nlm.nih.gov/pubmed/34835284

Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines. J Cardiovasc Med (Hagerstown), 23(2), 71-74. doi:10.2459/JCM.0000000000001232.

https://www.ncbi.nlm.nih.gov/pubmed/34366403

COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis. Pediatr Rep, 13(3), 530-533. doi:10.3390/pediatric13030061.

https://www.ncbi.nlm.nih.gov/pubmed/34564344
5
level 2
xxyiorgos
Op ·
16 days ago

Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine. Acta Paediatr, 111(1), 125-127. doi:10.1111/apa.16141.

https://www.ncbi.nlm.nih.gov/pubmed/34617315

Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?

https://www.ncbi.nlm.nih.gov/pubmed/34333695

Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina (Kaunas), 57(11). doi:10.3390/medicina57111163.

https://www.ncbi.nlm.nih.gov/pubmed/34833382

Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents. AJR Am J Roentgenol. doi:10.2214/AJR.21.26853.

https://www.ncbi.nlm.nih.gov/pubmed/34704459

Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings. J Korean Med Sci, 36(40), e286. doi:10.3346/jkms.2021.36.e286.

https://www.ncbi.nlm.nih.gov/pubmed/34664804

Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level. Clin Pharmacol Ther. doi:10.1002/cpt.2499.

https://www.ncbi.nlm.nih.gov/pubmed/34860360

Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clin Infect Dis. doi:10.1093/cid/ciab989.

https://www.ncbi.nlm.nih.gov/pubmed/34849657

Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? J Pediatr. doi:10.1016/j.jpeds.2021.12.026.

https://www.ncbi.nlm.nih.gov/pubmed/34933012

COVID vaccination and asthma exacerbation: might there be a link? Int J Infect Dis, 112, 243-246. doi:10.1016/j.ijid.2021.09.026.

https://www.ncbi.nlm.nih.gov/pubmed/34547487

Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J Pediatr, 238, 26-32 e21. doi:10.1016/j.jpeds.2021.07.044.

https://www.ncbi.nlm.nih.gov/pubmed/34339728

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far? Children (Basel), 8(7). doi:10.3390/children8070607.

https://www.ncbi.nlm.nih.gov/pubmed/34356586

Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database. J Prim Care Community Health, 12, 21501327211029230. doi:10.1177/21501327211029230.

https://www.ncbi.nlm.nih.gov/pubmed/34219532

A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging, 14(9), 1862-1863. doi:10.1016/j.jcmg.2021.06.003.

https://www.ncbi.nlm.nih.gov/pubmed/34246585

Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis Rheumatol. doi:10.1002/art.41977.

https://www.ncbi.nlm.nih.gov/pubmed/34492161

Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Ann Rheum Dis. doi:10.1136/annrheumdis-2021-221607.

https://www.ncbi.nlm.nih.gov/pubmed/34844930

Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clin Res Cardiol, 110(11), 1855-1859. doi:10.1007/s00392-021-01936-6.

https://www.ncbi.nlm.nih.gov/pubmed/34487236

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med, 385(19), 1774-1785. doi:10.1056/NEJMoa2113017.

https://www.ncbi.nlm.nih.gov/pubmed/34551225

Acute myocarditis in a young adult two days after Pfizer vaccination. G Ital Cardiol (Rome), 22(11), 891-893. doi:10.1714/3689.36746.

https://www.ncbi.nlm.nih.gov/pubmed/34709227

Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series. Rev Med Virol, e2318. doi:10.1002/rmv.2318.

https://www.ncbi.nlm.nih.gov/pubmed/34921468

Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses. Nat Commun, 12(1), 6844. doi:10.1038/s41467-021-27120-y.

https://www.ncbi.nlm.nih.gov/pubmed/34824230

Myocarditis and Pericarditis in Adolescents after First and Second doses of mRNA COVID-19 Vaccines. Eur Heart J Qual Care Clin Outcomes. doi:10.1093/ehjqcco/qcab090.

https://www.ncbi.nlm.nih.gov/pubmed/34849667

SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naive and Pre-Immune Humans. Front Immunol, 12, 728021. doi:10.3389/fimmu.2021.728021.

https://www.ncbi.nlm.nih.gov/pubmed/34646267

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis, 80(10), 1330-1338. doi:10.1136/annrheumdis-2021-220647.

https://www.ncbi.nlm.nih.gov/pubmed/34127481

COVID-19 in Children: Clinical Manifestations and Pharmacologic Interventions Including Vaccine Trials. Pediatr Clin North Am, 68(5), 961-976. doi:10.1016/j.pcl.2021.05.004.

https://www.ncbi.nlm.nih.gov/pubmed/34538306

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices – United States, June 2021. MMWR Morb Mortal Wkly Rep, 70(27), 977-982. doi:10.15585/mmwr.mm7027e2.

https://www.ncbi.nlm.nih.gov/pubmed/34237049

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase. Vaccines (Basel), 9(1). doi:10.3390/vaccines9010019.

https://www.ncbi.nlm.nih.gov/pubmed/33406694

A Late Presentation of COVID-19 Vaccine-Induced Myocarditis. Cureus, 13(9), e17890. doi:10.7759/cureus.17890.

https://www.ncbi.nlm.nih.gov/pubmed/34660088

Myocarditis after vaccination against covid-19. BMJ, 375, n3090. doi:10.1136/bmj.n3090.

https://www.ncbi.nlm.nih.gov/pubmed/34916217

The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract, 9(10), 3546-3567. doi:10.1016/j.jaip.2021.06.006.

https://www.ncbi.nlm.nih.gov/pubmed/34153517

Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disord, 21(1), 375. doi:10.1186/s12872-021-02183-3.

https://www.ncbi.nlm.nih.gov/pubmed/34348657

Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine. J Blood Med, 12, 221-224. doi:10.2147/JBM.S307047.

https://www.ncbi.nlm.nih.gov/pubmed/33854395

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ, 374, n1931. doi:10.1136/bmj.n1931.

https://www.ncbi.nlm.nih.gov/pubmed/34446426

A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore Med J. doi:10.11622/smedj.2021210.

https://www.ncbi.nlm.nih.gov/pubmed/34808708

Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report. Drug Saf, 44(11), 1209-1214. doi:10.1007/s40264-021-01104-9.

https://www.ncbi.nlm.nih.gov/pubmed/34347278

In brief: Myocarditis with the Pfizer/BioNTech and Moderna COVID-19 vaccines. (2021). Med Lett Drugs Ther, 63(1629), e9.

https://www.ncbi.nlm.nih.gov/pubmed/34544112https://www.ncbi.nlm.nih.gov/pubmed/3454412
5
Continue this thread 
level 1
xThrowaway1776
·
16 days ago
🚫💉 Fully Unvaccinated 🚫💉

Impressive length
4
level 1
SupremeGD
·
16 days ago

Oh hell yeah!
3
level 1
DiligentMeaning5649
·
16 days ago

tHaT mEaNs ItS wOrKiNg

bigot
3
level 1
eggydrums115
·
16 days ago

“But hundreds of millions of people have taken it!”
3
level 1
Comment removed by moderator ·
16 days ago
More posts from the CoronavirusCirclejerk community
920
Posted byu/SucculentDingleberry
5 days ago
Pfizer's worst nightmare 😱😱😱
But wait, there’s more!!!
112 comments
901
Posted byu/SECmydick
6 days ago
Sums it up
we all In this together...
11 comments
Continue browsing in r/CoronavirusCirclejerk